Research Profiles

Scientific Discovery

Ulrich G. Steidl, Ph.D., M.D.

Targeting Leukemia: Deactivating AML’s Key Protein

Ulrich Steidl, M.D., Ph.D., studies the molecular pathways that lead to the development of leukemia. He recently identi?ed a key protein responsible for causing acute myeloid leukemia, a particularly lethal and poorly treated form of cancer. He is now developing drugs that target and inactivate this protein—an entirely new approach to leukemia treatment. Dr. Steidl is assistant professor of cell biology and of medicine (oncology) and the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research.

Ulrich G. Steidl, Ph.D., M.D.

  • Professor, Department of Cell Biology
  • Professor, Department of Oncology (Medical Oncology)
  • Professor, Department of Medicine (Oncology & Hematology)
  • Rose C. Falkenstein Chair in Cancer Research
  • Deputy Director, and Associate Director for Basic Science, Albert Einstein Cancer Center
  • Interim Director, The Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research
  • The Diane and Arthur B. Belfer Faculty Scholar in Cancer Research
  • Co-Director, Blood Cancer Institute
 
 
 

Other Top Einstein Researchers